Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Die Pharmazie|August 17, 2024
Metabolism of baicalin by different microbiota determined by MimiColD-S Seradj, L Neubauer, S Senekowitsch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2001
Magnetic marker monitoring of disintegrating capsulesW Weitschies, M Karaus, D Cordini, et al.
Thrombosis Research|February 12, 2008
Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settingsA Greinacher, S Alban, M A Omer-Adam, et al.
Nanotechnology|March 30, 2011
Determination of energy barrier distributions of magnetic nanoparticles by temperature dependent magnetorelaxometryE Romanus, D V Berkov, S Prass, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 20, 2005
Nanoparticle composition of a ferrofluid and its effects on the magnetic propertiesK Büscher, C A Helm, C Gross, et al.
Investigative Radiology|February 1, 1997
Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emissionP Hauff, T Fritzsch, M Reinhardt, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2005
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imagingC Schiller, C-P Fröhlich, T Giessmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2015
Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studiesM Koziolek, F Schneider, M Grimm, et al.
Biomedizinische Technik. Biomedical Engineering|December 6, 2002
Investigation of gastrointestinal transport by magnetic marker localizationO Kosch, E Osmanoglou, V Hartman, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexesK Krauel, B Fürll, T E Warkentin, et al.
Pageof 4